Todos Medical Announces Exclusive License & Distribution Agreement with T Cell Protect Hellas S.A. for Tollovid^® Products Covering 30 Countries in Europe

Todos Medical, Ltd. announced that it has entered into an exclusive European licensing & distribution agreement with T Cell Protect Hellas S.A. for a product based on its Tollovid^® and Tollovid Daily™ 3CL protease inhibitor and immune support dietary supplements.